The neurostimulation market is expanding rapidly; remarkable growth rates of 11.5% are anticipated between 2022 and 2032. Numerous incapacitating illnesses, such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression, and essential tremors, are treated using neurostimulation. For individuals who have not seen relief from pharmacological or surgical procedures, it is a viable treatment option. Patients whose …